🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

27+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 7 of 27 recruiting trials for “MALT lymphoma”

NARecruitingNCT06190301 ↗

RCT on Intralesional Rituximab Injection Versus ISRT in Ocular Adnexal MALT Lymphoma

🏥 Zhongshan Ophthalmic Center, Sun Yat-sen University📍 2 sites📅 Started Jan 2024View details ↗
Phase 2RecruitingNCT06503276 ↗

The Treatment of Ocular Adnexal Extranodal Marginal Zone B-cell Lymphoma by Orelabrutinib and Radiotherapy

👨‍⚕️ Jun Shi, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University📍 1 site📅 Started Nov 2023View details ↗
Phase 1RecruitingNCT06026319 ↗

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

👨‍⚕️ Matthew Frigault, MD, Massachusetts General Hospital📍 1 site📅 Started Oct 2023View details ↗
Phase 3RecruitingNCT06006117 ↗

Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma

👨‍⚕️ Catherine THIEBLEMONT, Pr, Lymphoma Study Association📍 48 sites📅 Started Sep 2023View details ↗
Phase 2RecruitingNCT05929612 ↗

A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma

👨‍⚕️ Jillian Gunther, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Jul 2023View details ↗
Phase 4RecruitingNCT06134284 ↗

Clinical Study of OR for Second-line Treatment of Refractory MZL

👨‍⚕️ Chen, First Affiliated Hospital of Ningbo University📍 3 sites📅 Started Jan 2023View details ↗
Phase 3RecruitingNCT04834024 ↗

MIL62 Combined With Lenalidomide Versus Lenalidomide for Patients With Rituximab Refractory Follicular Lymphoma

🏥 Beijing Mabworks Biotech Co., Ltd.📍 1 site📅 Started Jun 2021View details ↗
← PreviousPage 2 of 2

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →